Immune-mediated liver injury

Journal of Hepatology

Volumn 52, Issue 1, 2010, Pages 136-144

  Lohse, Ansgar W ^a   Weiler Normann, Christina ^a   Tiegs, Gisa ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN;

CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; IMMUNE MEDIATED INJURY; KUPFFER CELL; LIVER INJURY; LIVER SINUSOID; LIVER TOXICITY; NATURAL KILLER T CELL; NONHUMAN; PARASITIC LIVER DISEASE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VIRUS HEPATITIS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SYSTEM; IMMUNITY; LIVER; LIVER DISEASES;

EID: 71149092271     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.10.016     Document Type: Conference Paper

References (77)

1. Zingkernagel R.M. Lymphocytic choriomeningitis virus and immunology. Curr Top Microbiol Immunol 263 (2002) 1-5
2. Wiegard C., Wolint P., Frenzel C., Cheruti U., Schmitt E., Oxenius A., et al. Defective T helper response of hepatocyte-stimulated CD4 T cells impairs antiviral CD8 response and viral clearance. Gastroenterology 133 (2007) 2010-2018
3. Rehr M., Cahenzli J., Haas A., Price D.A., Gostick E., Huber M., et al. Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J Virol 82 (2008) 3391-3404
4. Agnellini P., Wolint P., Rehr M., Cahenzli J., Karrer U., and Oxenius A. Impaired NFAT nuclear translocation result in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection. Proc Natl Acad Sci USA 104 (2007) 4565-4570
5. Lang P.A., Contaldo C., Georgiev P., El-Badry A.M., Recher M., Kurrer M., et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med 14 (2008) 756-761
6. Shevach E.M., DiPaolo R.A., Andersson J., Zhao D.M., Stephens G.L., and Thronton A.M. The lifestyle of naturally occurring CD4+ Cd25* foxp3* regulatory T cells. Immunol Rev 212 (2006) 60-73
7. Huter E.N., Stummvoll G.H., DiPaolo R.J., Glass D.D., and Shevach E.M. Cutting edge: antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease. J Immunol 181 (2008) 8209-8213
8. Shetty S., Lalor P.F., and Adams D.H. Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis. Toxicology 254 (2008) 134-146
9. Eksteen B., Afford S.C., Wigmore S.J., Holt A.P., and Adams D.H. Immune-mediated liver injury. Semin Liver Dis 27 (2007) 351-366
10. Holt A.P., Haughton E.L., Lalor P.F., Filer A., Buckley C.D., and Adams D.H. Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 136 (2009) 705-714
11. Swain M.G. Hepatic NKT cells: friend or foe?. Clin Sci (Lond) 114 (2008) 457-466
12. Santodomingo-Garzon T., Han J., Le T., Yang Y., and Swain M.G. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology 49 (2009) 1267-1276
13. Bowen D.G., McCaughan G.W., and Bertolino P. Intrahepatic immunity: a tale of two sites?. Trends Immunol 26 (2005) 512-517
14. Bertolino P., Heath W.R., Hardy C.L., Morahan G., and Miller J.F. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol 25 (1995) 1932-1942
15. Bowen D.G., Zen M., Holz L., Davis T., McCaughan G.W., and Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 114 (2004) 701-712
16. Knolle P.A., and Limmer A. Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells. Trends Immunol 22 (2001) 432-437
17. Schildberg F.A., Hegenbarth S.I., Schumak B., Scholz K., Limmer A., and Knolle P.A. Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. Eur J Immunol 38 (2008) 957-967
18. Klein I., Cornejo J.C., Polakos N.K., John B., Wuensch S.A., Topham D.J., et al. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 110 (2007) 4077-4085
19. Lohse A.W., Knolle P., Bilo K., Uhrig A., Waldmann C., Ibe M., et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 110 (1996) 1175-1181
20. Knolle P.A., Schmitt E., Jin S., Germann T., Duchmann R., Hegenbarth S., et al. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 116 (1999) 1428-1440
21. Lüth S., Huber S., Schramm C., Buch T., Zander S., Stadelmann C., et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 118 (2008) 3403-3410
22. Wiegard C., Frenzel C., Herkel J., Kallen K.J., Schmitt E., and Lohse A.W. Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells. Hepatology 42 (2005) 193-199
23. Guidotti L.G. The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection. Vaccine 20 suppl. 4 (2002) A80-A82
24. Iannacone M., Sitia G., Ruggeri Z.M., and Guidotti L.G. HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol 46 (2007) 719-726
25. Iannacone M., Sitia G., Isogawa M., Marchese P., Castro M.G., Lowenstein P.R., et al. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med 11 (2005) 1167-1169
26. Iannacone M., Sitia G., Narvaiza I., Ruggeri Z.M., and Guidotti L.G. Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. Clin Vaccine Immunol 14 (2007) 1532-1535
27. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443 (2006) 350-354
28. Northfield J.W., Kasprowicz V., Lucas M., Kersting N., Bengsch B., Kim A., et al. CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology 47 (2008) 396-406
29. Komatsu T., Lauer G.M., Pybus O.G., Ouchi K., Wong D., Ward S., et al. Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes. J Viral Hepat 13 (2006) 121-130
30. Protzer U., Seyfried S., Quasdorff M., Sass G., Svorcova M., Webb D., et al. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 133 (2007) 1156-1165
31. Quasdorff M., Hösel M., Odenthal M., Zedler U., Bohne F., Gripon P., et al. A concerted action of HNF4alpha and HNF1 alpha links hepatitis B virus replication to hepatocyte differentiation. Cell Microbiol 10 (2008) 1478-1490
32. Tan A.T., Koh S., Goh V., and Bertoletti A. Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective. J Gastroenterol Hepatol 23 (2008) 833-843
33. Icard V., Diaz O., Scholtes C., Perrin-Cocon L., Ramiere C., Bartenschlager R., et al. PLoS One 4 (2009) e4233
34. Appel N., Zayas M., Miller S., Krijnse-Locker J., Schaller T., Friebe P., et al. PLoS Pathog 4 (2008) e1000035
35. Paeshuyse J., Vliegen I., Coelmont L., Leyssen P., Tabarrini O., Herdewijn P., et al. Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors. Antimicrob Agents Chemother 52 (2008) 3433-3437
36. Urbani S., Amadei B., Fisicaro P., Tola D., Orlandini A., Sacchelli L., et al. PD-1 expression in acute hepatitis C virus (HcV) infection is associated with HCV-specific exhaustion. J Virol 80 (2006) 11398-11403
37. Dandri M., Burda M.R., Zuckerman D.M., Wursthorn K., Matschl U., Pollok J.M., et al. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes. J Hepatol 42 (2005) 54-60
38. Petersen J., Burda M.R., Dandri M., and Rogler C.E. Transplantation of human hepatocytes in immunodeficient UPA mice: a model for the study of hepatitis B virus. Methods Mol Med 96 (2004) 253-260
39. Petersen J., Dandri M., Mier W., Lütgehetmann M., Volz T., von Weizsacker F., et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 26 (2008) 335-341
40. Lepenies B., and Jacobs T. The role of negative costimulators during parasitic infections. Endocr Metab Immune Disord Drug Targets 8 (2008) 279-288
41. Lepenies B., Gaworski I., Tartz S., Langhorne J., Fleischer B., and Jacobs T. CTLA-4 blockade differentially influences the outcome of non-lethal and lethal Plasmodium yoelii infections. Microbes Infect 9 (2007) 687-694
42. Jacobs T., Graefe S.E., Niknafs S., Gaworski I., and Fleischer B. Murine malaria is exacerbated by CTLA-4 blockade. J Immunol 169 (2002) 2323-2329
43. Engewerda C.R., Ato M., and Kaye P.M. Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol 20 (2004) 524-530
44. Lotter H., Jacobs T., Gaworski I., and Tannich E. Sexual dimorphism in the control of amoebic liver abscess in a mouse model of disease. Infect Immun 74 (2006) 118-124
45. Anthony R.M., Rutitzky L.I., Urban J.F.J., Stadecker M.J., and Gause W.C. Protective immune mechanisms in helminth infection. Nat Rev Immunol 7 (2007) 975-987
46. Shainheit M.G., Smith P.M., Bazzone L.E., Wang A.C., Rutitzky L.I., and Stadecker M.J. Dendritic cell IL-23 and IL-1 production in response to schistosome eggs induces Th17 cells in a mouse strain prone to severe immunopathology. J Immunol 181 (2008) 8559-8567
47. Tilg H., and Moschen A.R. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 14 (2008) 222-231
48. Tilg H., and Moschen A.R. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab 19 (2008) 371-379
49. Tilg H., and Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6 (2006) 772-783
50. Day C.P. From fat to inflammation. Gastroenterology 130 (2006) 207-210
51. Wilfred de Alwis N.M., and Day C.P. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis 27 (2007) 44-54
52. Nowell M.A., Williams A.S., Carty S.A., Scheller J., Hayes A.J., Jones G.W., et al. Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol 182 (2009) 613-622
53. Tenhumberg S., Waetzig G.H., Chalaris A., Rabe B., Seegert D., Scheller J., et al. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130. J Biol Chem 283 (2008) 27200-27207
54. Rose-John S., Waetzig G.H., Scheller J., Grötzinger J., and Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11 (2007) 613-624
55. Dierssen U., Beraza N., Lutz H.H., Liedtke C., Ernst M., Wasmuth H.E., et al. Molecular dissection of gp130-dependent pathways in hepatocytes during liver regeneration. J Biol Chem 283 (2008) 9886-9895
56. Christen U., and von Herrath M.G. Infections and autoimmunity - good or bad?. J Immunol 174 (2005) 7481-7486
57. Holdener M., Hintermann H., Rhode A., Wolfe T., Gonzalez F.J., Johnson E.F., et al. A novel model for human autoimmune hepatitis: breaking tolerance to human CYP2D6 by viral infection. J Exp Med 205 (2008) 1409-1422
58. Christen U., and von Herrath M.G. Apoptosis of autoreactive CD8 lymphocytes as a potential mechanism for the abrogation of type 1 diabetes by islet-specific TNF-alpha expression at a time when the autoimmune process is already ongoing. Ann NY Acad Sci 958 (2002) 166-169
59. Longhi M.S., Hussain M.J., Mitry R.R., Arora S.K., Mieli-Vergani G., Vergani D., et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 176 (2006) 4484-4491
60. Longhi M.S., Ma Y., Mitry R.R., Bogdanos D.P., Heneghan M.A., Cheeseman P., et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 25 (2005) 63-71
61. Longhi M.S., Hussain M.J., Bogdanos D.P., Quaglia A., Mieli-Vergani G., Ma Y., et al. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology 46 (2007) 472-484
62. Ma Y., Bogdanos D.P., Hussain M.J., Underhill J., Bansal S., Longhi M.S., et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 130 (2006) 868-882
63. Wies I., Brunner S., Henninger J., Herkel J., Kanzler S., Meyer zum Buschenfelde K.H., et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355 (2000) 1510-1515
64. Baeres M., Herkel J., Czaja A.J., Wies I., Kanzler S., Cancado E.L., et al. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 51 (2002) 259-264
65. Yuan J., Palioura S., Salazar J.C., Su D., O'Donoghue P., Hohn M.J., et al. RNA-dependent conversion of phosphoserin forms selenocysteine in eukaryotes and archaea. Proc Natl Acad Sci USA 103 (2006) 18923-18927
66. Mix H., Weiler-Normann C., Thimme R., Ahlenstiel G., Shin E.C., Herkel J., et al. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology 135 (2008) 2107-2118
67. Chuang Y.H., Ridgway W.M., Ueno H., and Gershwin M.E. Animal models of primary biliary cirrhosis. Clin Liver Dis 12 (2008) 333-347
68. Mao T.K., Davis P.A., Odin J.A., Coppel R.L., and Gershwin M.E. Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology 40 (2004) 1241-1248
69. Lleo A., Battenzzati P.M., Selmi C., Gershwin M.E., and Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 7 (2008) 626-630
70. Baghdasaryan A., Fickert P., Fuchsbichler A., Silbert D., Grumhold J., Hörl G., et al. Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice. Liver Int 28 (2008) 948-958
71. Schramm C., and Lohse A.W. Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis. Clin Rev Allergy Immunol 28 (2005) 105-114
72. Schramm C., and Galle P.R. Primary sclerosing cholangitis is a premalignant condition. Z Gastroenterol 43 (2005) 607-611
73. Ermolaeva M.A., Michallet M.C., Papadopoulou N., Utermöhlen O., Kranidioti K., Kollias G., et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 9 (2008) 1037-1046
74. Heinrichsdorff J., Luedde T., Perdiguero E., Nebreda A.R., and Pasparakis M. P38 alpha MAPK inhibits JNK activation and collaborates with IkappaB kinase 2 to prevent endotoxin-induced liver failure. EMBO Rep 9 (2008) 1048-1054
75. Luedde T., Beraza N., Kotsikoris V., van Loo G., Nenci A., De Vos R., et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11 (2007) 119-132
76. Katzenellenbogen M., Mizrahi L., Pappo O., Klopstock N., Olam D., Jacob-Hirsch J., et al. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice. Mol Cancer Res 5 (2007) 1159-1170
77. Katzenellenbogen B.S., Pappo O., Barash H., Klopstock N., Mizrahi L., Olam D., et al. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice. Cancer Res 66 (2006) 4001-4010